Paper Details

Paper Title

Treatment of hairy cell leukemia.

Paper Journal Title

Expert Rev Hematol

Paper Citation Count

Paper Publication Year

2020

Bio Mention

Anti-CD22 recombinant, BRAF, BTK, Bruton's tyrosine kinase, CD20 Mabs, CD20 antibody, HCL, IGHV4, IGHV4-34+, IGHV4-34+ unmutated HCL, MEK, MRD, Moxe, Moxetumomab Pasudotox, Purine, Rituximab, adenopathy, dabrafenib, hairy cell leukemia, ibrutinib, obinutuzumab, patients, purine, rituximab, trametinib, tyrosine, vemurafenib

Mesh Descriptor

Author Name	Affiliation
Robert J Kreitman	Center for Cancer Research, National Cancer Institute, National Institutes of Health
Robert J Kreitman	Center for Cancer Research, National Cancer Institute, National Institutes of Health

1 - 2

Dataset	Description	Source Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link

1 - 15

Paper Details

Column Actions

Datasets